ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

European Union and UK Pharma Regulatory Affairs for Support Staff Training Course | Current and Proposed Changes for Product Registration and Market Maintenance (ONLINE EVENT: September 22-23, 2025) - ResearchAndMarkets.com

The "Regulatory Affairs for Support Staff Training Course" training has been added to ResearchAndMarkets.com's offering.

Attend this interactive course to gain a valuable introduction to pharmaceutical regulatory affairs and key responsibilities, essential for those in support or interactive roles.

Navigating the complexities of regulatory processes, particularly in the context of evolving legislation, can be challenging. This is where an understanding of pharmaceutical regulatory affairs is important.

This interactive course is designed for professionals in support or interactive roles, offering a valuable introduction to pharmaceutical regulatory affairs and their key responsibilities.

Participants will gain an overview of current and proposed changes to EU legislation and regulatory procedures necessary to register products in the EU and the regulatory activities required to maintain products on the market. The UK is no longer a member of the EU but interactions and collaboration with the EU and other regulatory agencies for obtaining and maintaining marketing authorisations in the UK will be discussed.

This course aims to enhance understanding of the role of regulatory affairs, enabling support staff to perform more effectively and efficiently.

Interactive discussion sessions and practical case studies will help to consolidate learning, providing attendees with the skills and knowledge to be effective in their roles within the pharmaceutical industry.

Benefits of attending

  • Understand the background of EU law - regulations, directives and guidelines
  • Gain an understanding of the Common Technical Document
  • Discuss how to apply for a marketing authorisation in the EU via the centralised, decentralised and mutual recognition procedures
  • Clarify post-authorisation obligations - pharmacovigilance, variations and renewals
  • Contribute to your Continuing Professional Development (CPD)

Certifications:

  • CPD: 12 hours for your records
  • Certificate of completion

Who Should Attend:

This course is designed for personnel wishing to gain an understanding of regulatory affairs in the pharmaceutical industry, including:

  • Administrators
  • Assistants
  • Support Staff

Key Topics Covered:

Day 1

Current EU legislation

  • Background
  • Proposed changes to EU legislation
  • The Internet
  • Other sources

Drug Development

  • Pharmaceutical R&D
  • Non-clinical tests
  • Clinical studies - Phase I to IV

Clinical trials in Europe

Seeking scientific advice in Europe

Marketing Authorisations

  • Types of and categories for marketing authorisations

Overview of the structure and content of a CTD

Procedures for Marketing Authorisation in the EU

EU centralised procedures

  • The EMA
  • The Centralised Procedure (CP)
  • Referral and arbitration

Day 2

Non-centralised procedures for marketing authorisation in the EU and in the UK

  • Co-ordination Group
  • Decentralised procedure (DCP)
  • Mutual recognition procedure (MRP)
  • National procedures
  • Procedures in the UK

Abridged applications and generics

  • Types and requirements

Product life cycle; post-approval

Parallel trade

Post-authorisation obligations

Pharmacovigilance

Licence variations

  • Types and timelines

Extensions

Renewals

Sunset clause

Managing and supporting a regulatory affairs department

For more information about this training visit https://www.researchandmarkets.com/r/gca236

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.